The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury

被引:0
|
作者
Chao Zhang
Shuo Wang
Jiawei Li
Weitao Zhang
Long Zheng
Cheng Yang
Tongyu Zhu
Ruiming Rong
机构
[1] Zhongshan Hospital,Department of Urology
[2] Fudan University,Department of Transfusion
[3] Shanghai Key Laboratory of Organ Transplantation,undefined
[4] Shanghai Public Health Clinical Center,undefined
[5] Fudan University,undefined
[6] Zhongshan Hospital,undefined
[7] Fudan University,undefined
来源
Cell Death & Disease | 2017年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mammalian target of rapamycin (mTOR) signal controls innate and adaptive immune response in multiple immunoregulatory contexts. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of myeloid cells of potent immunosuppressive capacity. In this study, we aimed to investigate the role of MDSCs in the protection of acute kidney injury (AKI) and the regulation of mTOR signal on MDSC’s protective role in this context. In mice AKI model, rapamycin administration was associated with improved renal function, restored histological damage and decreased CD4+ and CD8+ T-cell infiltration in kidney tissue. MDSCs, especially CD11b+Ly6G+Ly6Clow G-MDSCs were recruited to the injured kidney following the interaction of CXCL1, CXCL2 and their receptor CXCR2 after inhibiting mTOR signal with rapamycin treatment. The adoptive transfer of rapamycin-treated MDSCs into the mice with AKI significantly improved the renal function, ameliorated histologic damages and limited the infiltration of T cells in kidney tissue. In addition, the expression of pro-inflammatory cytokines IL-1β and IFN-γ mRNA was downregulated while the expression of TGF-β1 and Foxp3 mRNA was upregulated in kidney tissue after transferring rapamycin-treated MDSCs. Adoptive transfer of rapamycin-treated MDSCs also downregulated the serum levels of IL-1β, IL-6 and IFN-γ and upregulated the serum levels of TGF-β1 compared with the IR group and PBS-treated MDSC group. In in vitro study, inhibiting mTOR signal regulated the induction of MDSC towards the CD11b+Ly6G+Ly6Clow G-MDSC subset. The ability to suppress T-cell proliferation of both bone marrow–derived CD11b+Ly6G+Ly6Clow G-MDSCs and CD11b+Ly6G-Ly6Chigh M-MDSCs was enhanced by mTOR signal inhibition via upregulating the expression of Arginase-1 and iNOS. Accordingly, both G-MDSCs and M-MDSCs presented downregulated runx1 gene expression after rapamycin treatment. Taken together, our results demonstrated that MDSCs ameliorated AKI and the protective effect was enhanced by mTOR signal inhibition via promoting MDSCs recruitment, regulating the induction of MDSCs and strengthening their immunosuppressive activity.
引用
收藏
页码:e2695 / e2695
相关论文
共 50 条
  • [21] Soluble Fibrinogen-Like Protein 2 Regulates Myeloid-Derived Suppressor Cells Differentiation and Enhances Its Immunosuppressive Function of in Allograft Immunity.
    Yang, C.
    Zhu, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 501 - 501
  • [22] Endoplasmic reticulum stress regulates immunosuppressive function of myeloid derived suppressor cells in leprosy
    Kelly-Scumpia, Kindra
    Shirazi, Roksana
    Modlin, Robert
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [23] Valproic acid reduces the immunosuppressive activity of myeloid-derived suppressor cells
    Xie, Zhiqi
    Okada, Naoki
    Tachibana, Masashi
    CANCER SCIENCE, 2018, 109 : 1177 - 1177
  • [24] Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
    Kai Li
    Houhui Shi
    Benxia Zhang
    Xuejin Ou
    Qizhi Ma
    Yue Chen
    Pei Shu
    Dan Li
    Yongsheng Wang
    Signal Transduction and Targeted Therapy, 6
  • [25] Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells
    Garritson, Jacob
    Krynski, Luke
    Haverbeck, Lea
    Haughian, James M.
    Pullen, Nicholas A.
    Hayward, Reid
    PLOS ONE, 2020, 15 (06):
  • [26] Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients
    Wang, Ying
    Li, Peng
    Wang, Bo
    Wang, Shuai
    Liu, Pinan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 523 - 533
  • [27] Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients
    Ying Wang
    Peng Li
    Bo Wang
    Shuai Wang
    Pinan Liu
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 523 - 533
  • [28] Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
    Li, Kai
    Shi, Houhui
    Zhang, Benxia
    Ou, Xuejin
    Ma, Qizhi
    Chen, Yue
    Shu, Pei
    Li, Dan
    Wang, Yongsheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [29] Neuroregenerative and Immunosuppressive actions of Myeloid-derived Suppressor Cells (MDSCs) in the Cornea
    Sarkar, Joy
    Kim, Eunjae
    Chaudhary, Shweta
    Byun, Yong Soo
    Tibrewal, Sapna
    Ivanir, Yair
    Wahood, Rama
    Mohindra, Neil
    Leonard, Kaele
    Jain, Sandeep
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [30] β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
    Mohammadpour, Hemn
    MacDonald, Cameron R.
    Qiao, Guanxi
    Chen, Minhui
    Dong, Bowen
    Hylander, Bonnie L.
    McCarthy, Philip L.
    Abrams, Scott I.
    Repasky, Elizabeth A.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (12): : 5537 - 5552